Risk of postmenopausal hormone therapy and patient history factors for the survival rate in women with endometrial carcinoma

ConclusionsAge (the older, the worse) and tumor stage (the higher, the worse) were significant influences on overall survival. Patients with HT also had lower BMIs, less diabetes, more type I EC, and fewer recurrences in comparison with the non-HT group. With regard to the PFS, it made no difference whether the patient was receiving HT.
Source: Archives of Gynecology and Obstetrics - Category: OBGYN Source Type: research